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Expression and Assembly of Largest Foreign Protein in Chloroplasts: Oral
Delivery of Human FVIII Made in Lettuce Chloroplasts Robustly Suppresses
Inhibitor Formation in Haemophilia A Mice
Abstract
Inhibitor formation is a serious complication of factor VIII (FVIII) replacement therapy for the X‐linked
bleeding disorder haemophilia A and occurs in 20%–30% of patients. No prophylactic tolerance protocol
currently exists. Although we reported oral tolerance induction using FVIII domains expressed in tobacco
chloroplasts, significant challenges in clinical advancement include expression of the full‐length
CTB‐FVIII sequence to cover the entire patient population, regardless of individual CD4+ T‐cell epitope
responses. Codon optimization of FVIII heavy chain (HC) and light chain (LC) increased expression 15‐ to
42‐fold higher than the native human genes. Homoplasmic lettuce lines expressed CTB fusion proteins of
FVIII‐HC (99.3 kDa), LC (91.8 kDa), C2 (31 kDa) or single chain (SC, 178.2 kDa) up to 3622, 263, 3321 and
852 μg/g in lyophilized plant cells, when grown in a cGMP hydroponic facility (Fraunhofer). CTB‐FVIII‐SC
is the largest foreign protein expressed in chloroplasts; despite a large pentamer size (891 kDa),
assembly, folding and disulphide bonds were maintained upon lyophilization and long‐term storage as
revealed by GM1‐ganglioside receptor binding assays. Repeated oral gavages (twice/week for 2 months)
of CTB‐FVIII‐HC/CTB‐FVIII‐LC reduced inhibitor titres ~10‐fold (average 44 BU/mL to 4.7 BU/mL) in
haemophilia A mice. Most importantly, increase in the frequency of circulating LAP‐expressing CD4+
CD25+FoxP3+ Treg in tolerized mice could be used as an important cellular biomarker in human clinical
trials for plant‐based oral tolerance induction. In conclusion, this study reports the first clinical candidate
for oral tolerance induction that is urgently needed to protect haemophilia A patients receiving FVIII
injections.
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Summary
Inhibitor formation is a serious complication of factor VIII (FVIII) replacement therapy for the Xlinked bleeding disorder haemophilia A and occurs in 20%–30% of patients. No prophylactic
tolerance protocol currently exists. Although we reported oral tolerance induction using FVIII
domains expressed in tobacco chloroplasts, significant challenges in clinical advancement include
expression of the full-length CTB-FVIII sequence to cover the entire patient population, regardless
of individual CD4+ T-cell epitope responses. Codon optimization of FVIII heavy chain (HC) and
light chain (LC) increased expression 15- to 42-fold higher than the native human genes.
Homoplasmic lettuce lines expressed CTB fusion proteins of FVIII-HC (99.3 kDa), LC (91.8 kDa),
C2 (31 kDa) or single chain (SC, 178.2 kDa) up to 3622, 263, 3321 and 852 lg/g in lyophilized
plant cells, when grown in a cGMP hydroponic facility (Fraunhofer). CTB-FVIII-SC is the largest
foreign protein expressed in chloroplasts; despite a large pentamer size (891 kDa), assembly,
folding and disulphide bonds were maintained upon lyophilization and long-term storage as
revealed by GM1-ganglioside receptor binding assays. Repeated oral gavages (twice/week for
2 months) of CTB-FVIII-HC/CTB-FVIII-LC reduced inhibitor titres ~10-fold (average 44 BU/mL to
4.7 BU/mL) in haemophilia A mice. Most importantly, increase in the frequency of circulating
LAP-expressing CD4+CD25+FoxP3+ Treg in tolerized mice could be used as an important cellular
biomarker in human clinical trials for plant-based oral tolerance induction. In conclusion, this
study reports the first clinical candidate for oral tolerance induction that is urgently needed to
protect haemophilia A patients receiving FVIII injections.

Introduction
The serine protease factor IX (FIX) and its cofactor, factor VIII
(FVIII), circulate in the blood in their inactive form. Upon their
activation, they form an enzymatic complex that is a critical
component of the coagulation cascade, which promotes blood
clot formation, thereby aiding in vascular injury repair. However,
approximately one in 5000 boys worldwide is born with the
bleeding disorder haemophilia resulting from mutations on the X
chromosome. The majority of patients lack FVIII activity (haemophilia A), while the remainder lack FIX (haemophilia B). Currently,
treatment of haemophilia is primarily based on replacement
therapy by intravenous infusion of recombinant or plasmaderived factor concentrate. Unfortunately, 20%–30% of haemophilia A patients develop inhibitory antibodies (‘inhibitors’) against
FVIII that severely complicate treatment and increase morbidity
and mortality risk (Lai and Lillicrap, 2017). These inhibitors
typically develop in young children during the first 50 days of
exposure to the therapeutic FVIII protein. Immune tolerance
induction (ITI) protocols are able to eradicate inhibitors with a
success rate of approximately 60% (Kempton and Meeks, 2014).
ITI utilizes daily high-dose intravenous FVIII infusions and can take
months or even years to complete, often posing costs of >
$1 000 000. During that time, bypass agents can restore
1148

haemostasis, but require careful dosing to prevent thrombosis,
and increased potential for morbidity and mortality remain during
that time (Rocino et al., 2017). Progress has been made in
defining the risk factors for inhibitor formation. However, there
are no prophylactic immune tolerance protocols to prevent
inhibitor formation. Similar challenges exist in replacement
therapies for other genetic diseases as a result of antidrug
antibody formation, such as for the lysosomal storage disorder
Pompe disease, prompting the prolonged use of immunesuppressive drugs (Doerfler et al., 2016; Elder et al., 2013).
Although there are a number of recent innovative approaches
to induce FVIII-specific immune tolerance, developing a clinically
feasible protocol that is acceptable for use in paediatric patients
and avoids nonspecific immune suppression remains a challenge
(Batsuli et al., 2016; Wang et al., 2016). Oral antigen administration represents a potential solution to this problem (Kuhn and
Weiner, 2016; Rezende and Weiner, 2017; Wang et al., 2013).
The gut immune system has evolved mechanisms to prevent
pathogenic immune response to food antigens. Therefore, orally
administered antigens, similar to food antigens, may be taken up
by the small intestine’s immune system, resulting in an immune
regulatory response. This concept has recently been successfully
employed in children with severe food allergies (Hamad and
Burks, 2017). A perhaps greater challenge is to adapt this concept
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to therapeutic proteins, which will have to be manufactured in a
cost-efficient manner, formulated to be protected from degradation before reaching the gut, and effectively targeted to the
small intestine’s immune system in order to achieve an immune
regulatory response that is capable of systemically suppressing
immune responses to the specific antigen. We developed a
platform to accomplish these goals by expression of protein
antigens (fused to transmucosal carrier proteins) in chloroplasts of
crop plants. These plants achieve expression of effective antigen
doses, while also providing natural bioencapsulation by the cell
wall and avoiding the need for expensive protein purification
(Daniell et al., 2016a,b; Kwon and Daniell, 2016; Kwon et al.,
2013a). Importantly, this concept has been successfully applied in
murine models of haemophilia A and B and Pompe disease, and
even in a large (canine) model of haemophilia B, illustrating
translatability to other species (Herzog et al., 2017; Sherman
et al., 2014; Su et al., 2015a,b; Verma et al., 2010).
Using a murine model of haemophilia A, we previously
demonstrated in a proof-of-principle study that oral delivery of
FVIII domains bioencapsulated in frozen leaf cells of transplastomic tobacco suppresses inhibitor formation. This was accomplished using the heavy chain and C2 domain of B domaindeleted (BDD) FVIII (one of the therapeutic FVIII variants used in
replacement therapy for haemophilia A) as tolerogenic antigens.
However, expression of the full-length protein antigen is needed
to cover the entire patient population, regardless of individual
CD4+ T-cell epitopes that induce inhibitory antibodies against
FVIII. This requires optimization of chloroplast expression of large
human blood proteins in edible leaves, evaluation of their stability
at room temperature, protection of antigens in the stomach from
acids and enzymes, successful release of antigens in the gut
lumen and delivery to the immune system (Daniell et al., 2015,
2016b; Kwon and Daniell, 2015, 2016).
Chloroplasts express small human blood proteins very efficiently. CTB-fused human proinsulin was expressed in chloroplasts 53%–72% of total leaf protein (22.5 kDa – Boyhan and
Daniell, 2011; Ruhlman et al., 2010). Other smaller human
therapeutic proteins including human insulin-like growth factor-1
(25 kDa – Daniell et al., 2009), human interferon alpha 2B
(21.5 kDa – Arlen et al., 2007), TGF-Beta (13 kDa – Gisby et al.,
2011), were also expressed at high levels in chloroplasts. In
contrast, larger native human gene like CTB-fused human
coagulation factor IX (59.2 kDa) was expressed only up to
0.56% of total lettuce leaf protein (Su et al., 2015b). Likewise,
native coagulation factor VIII (FVIII) heavy chain (HC, 86.4 kDa)
was expressed <0.05% of the total leaf proteins (Kwon et al.,
2016). Such low levels of expression of large proteins are not due
to low abundance of transcripts because it is heavily compensated
by the high copy number of chloroplast genomes. We recently
developed a codon optimizer program to increase transgene
expression in lettuce and tobacco chloroplasts utilizing a wealth
of newly sequenced chloroplast genomes. While the removal of
rare codons is very important, replacing those with only the most
highly used psbA codons decreased translation efficiency because
of transfer RNA (tRNA) and other limitations (Kwon et al., 2016).
Translation enhancement of human genes was achieved by
replacement of rare codons following the hierarchy of the highly
expressed chloroplast psbA gene. Therefore, there is a greater
need to optimize expression of large human genes in chloroplasts
for advancing them to the clinic.
In addition to challenges in expression of large human genes in
chloroplasts, there are major obstacles for oral delivery of protein

drugs. When orally delivered, protein drugs are degraded by acid
and pepsin in the stomach, their bioavailability is dramatically
reduced. In addition, proteins encounter several permeability
barriers in the gut epithelium. Therefore, current protein drug
delivery system is totally dependent on injections, which has been
a major hurdle for lowering production cost, enhancing protein
stability and increasing patient compliance. To address these
issues, several other delivery methods including nasal, buccal,
pulmonary, ocular, rectal and transdermal routes have been
investigated with limited success (Kwon et al., 2013a). Attempts
to enhance efficiency of oral delivery system have been made
using protease inhibitors, mucoadhesion and absorption enhancers, and delivery vehicles formulated with emulsions, liposomes,
microspheres and nanoparticles (Kwon et al., 2013a). Although
many oral formulations have been developed to increase permeability and/or bioavailability of protein drugs, further studies are
required for their dose-dependent delivery (Kwon and Daniell,
2016).
Aforementioned challenges can be addressed by bioencapsulation of protein drugs within plant cells because plant cell wall is
not digested by enzymes and low pH in the stomach. Upon
reaching the intestine, plant cell wall is digested by enzymes
secreted from commensal bacteria including Bacteroidetes and
Firmicutes (Flint et al., 2012; Koropatkin et al., 2012). The
released proteins cross the epithelial physical barrier with the
help of fusion tags to reach circulation or immune system (Xiao
et al., 2016). Also, freeze-dried plant cells can be stored at
ambient temperature for several years, preserving folding and
assembly of protein drugs with no loss of functionality (Daniell
et al., 2016a,b; Herzog et al., 2017; Su et al., 2015b). In
addition, the removal of water from plant cells during lyophilization enhances concentration of protein drugs based on weight
and facilitates oral drug delivery. Furthermore, cultivation of
plants in confined optimal growth conditions in current Good
Manufacturing Processes (cGMP) hydroponic system facilitates
clinical development of plant-made biopharmaceuticals. Application of this system has been evaluated in animal models of various
human diseases including Alzheimer’s (Kohli et al., 2014),
pulmonary hypertension (Shenoy et al., 2014), diabetes (Boyhan
and Daniell, 2011; Kwon et al., 2013b; Ruhlman et al., 2007) and
retinopathy (Shil et al., 2014). Most importantly, this approach is
suitable for induction of oral tolerance to therapeutic proteins
used in replacement therapy of genetic diseases, as demonstrated
in Pompe disease (Su et al., 2015a) and haemophilia (Herzog
et al., 2017; Sherman et al., 2014; Wang et al., 2015) by
suppression of immunoglobulin formation.
In this study, we achieved expression of the CTB fusion proteins
of FVIII light chain (LC), C2 domain (C2) and the entire BDD
human FVIII protein (SC) in lettuce chloroplasts to levels required
for clinical translation and produced them in a cGMP facility at
Fraunhofer USA. CTB-FVIII-SC is the largest foreign protein
expressed so far in chloroplasts and the size of the assembled
pentameric structure is 891 kDa; this is stable in lyophilized cells
when stored at ambient temperature for several months with
proper folding, disulphide bonds and assembly. All four CTB-FVIII
proteins (HC, LC, SC, C2) expressed in lettuce chloroplasts were
tested for the first time in animal studies. Furthermore, we show
that low oral antigen doses in lyophilized lettuce cells are effective
in suppression of inhibitor formation against FVIII injections and
identified a cellular biomarker of oral tolerance induction in
peripheral blood cells useful in human clinical trials. These
accomplishments augur well for advancing the first clinical
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candidate for oral tolerance induction to meet this unmet and
urgent need for protecting haemophilia A patients receiving FVIII
injections.

Results
Codon optimization and evaluation of human FVIII
expression in E. coli
In our previous study (Sherman et al., 2014), expression level of
the native human FVIII-HC gene in tobacco chloroplasts was very
low and tobacco system is not suitable for clinical studies. To
enhance expression level of FVIII proteins in lettuce chloroplasts
and to cover the entire FVIII sequence for the improved induction
of oral tolerance, the genes for the heavy chain (HC) and light
chain (LC) were codon-optimized on the basis of the analysis of
the most highly expressed psbA genes (Kwon et al., 2016). Rare
codons were replaced by highly preferred codons and the
hierarchy of codon usage of the chloroplast psbA gene was
matched during the codon optimization process.
In codon-optimized genes (Figure S1), 406 of 754 codons for
FVIII-HC including B domain (14 codons) and 445 of 684 codons
for FVIII-LC were optimized, which increased AT content from
56% to 62%. To obtain full-length FVIII and B domain-deleted
sequence (FVIII-BDD single chain, SC), the separately codonoptimized FVIII-HC and FVIII-LC were fused by assembly PCR. In
case of the cholera nontoxic subunit B (CTB), used as a
transmucosal carrier protein, the native sequence was employed
due to its high-level expression in plant chloroplasts (Boyhan and
Daniell, 2011; Ruhlman et al., 2010). The native human FVIII-C2
gene was expressed at very high levels in tobacco chloroplasts
(Sherman et al., 2014), more than adequate for translation, and
therefore, this sequence was moved from tobacco to lettuce
chloroplast vectors.
In the chloroplast vector expression cassette (Figure 1a), the
native CTB sequence is followed by hinge (Gly-Pro-Gly-Pro) and
furin cleavage site (Arg-Arg-Lys-Arg-Ser-Val, Duckert et al., 2004)
to avoid any steric hindrance and to facilitate efficient release of
the fused FVIII proteins (Figure S1). The CTB-fused FVIII genes are
driven by strong psbA promoter/5ʹ-UTR, which is most widely
used for high expression of transgenes in chloroplasts (Daniell
et al., 2016b), and the transcripts of the fusion genes are
stabilized by the psbA 3ʹ-UTR. To ensure site-specific integration
of expression cassettes into lettuce chloroplast genomes by
double homologous recombination, 30 half of 16s rRNA, trnI
genes (2098 bp) and trnA, 50 half 23s rRNA (2047 bp) flanked
both ends of the cassettes. Aminoglycoside-30 -adenylyltransferase selectable marker gene (aadA) is driven by ribosomal RNA
promoter (Prrn).
After construction of the codon-optimized synthetic genes
into chloroplast transformation vectors, translation efficiency of
the synthetic genes over native sequences was tested in E. coli
because of similarity of both expression systems in transcription
and translation (Brixey et al., 1997). All three CTB fusion
proteins, FVIII-HC (99.3 kDa), FVIII-LC (91.8 kDa) and FVIII-SC
(178.2 kDa), were detected at the expected sizes (Figure 1b).
According to the immunoblot results (Figure 1b), at equal
loading amount (1 lg of total protein), the corresponding
polypeptides of CTB-FVIII-HC and CTB-FVIII-LC were barely
detectable. In contrast, expression level of codon-optimized
CTB-FVIII-HC and CTB-FVIII-LC genes in E. coli increased 15- to
42-fold. These results indicate that codon optimization system is
very effective in improving FVIII expression.

Creation and evaluation of homoplasmic transplastomic
lettuce lines expressing codon-optimized human FVIII
genes
The CTB-FVIII gene constructs were delivered into the lettuce
chloroplasts by biolistic particle delivery system. Transplastomic
plants were selected on spectinomycin and examined by PCR
amplification of genomic DNA (Figure 1). The PCR results of all
independent lettuce lines examined confirmed site-specific integration of CTB-FVIII-LC (Figure 1c) and CTB-FVIII-SC (Figure 1d).
The specific integration of the FVIII expression cassettes into
lettuce chloroplast genome was evaluated using primers: 16sF,
annealed to the endogenous 16s rRNA gene outside the
expression cassettes, and 3M, annealed to the aadA gene in
the expression cassettes (Figure 1a), resulting in the exclusion of
off-target integration of the expression cassettes into nuclear or
mitochondrial genomes. The homoplasmic lettuce transplastomic
lines expressing the native CTB-FVIII-C2 sequence (31.0 kDa)
were confirmed using specific primer sets including 16sF and 3M.
In addition, internal primers annealing to different sequences
within the expression cassette (5P, H-R, L-F, P-F, T-R, Figure 1a)
were used to exclude any false-positive spectinomycin resistant
mutants. Therefore, these lines were further evaluated for
homoplasmic or heteroplasmic status by Southern blot
hybridization.
For CTB-FVIII-LC and CTB-FVIII-SC lettuce transplastomic lines,
extracted total genomic DNA digested with HindIII, and transferred membranes blotted with fragmented genomic DNA were
probed with flanking region probe (SB-P, Figure 1a). In CTB-FVIIILC lettuce lines, the DIG-labelled probe specifically detected the
transformed genomic DNA fragment at 13.7 kb (Figure 2a) with
no wild-type hybridizing fragment at 9.1 kb. In wild-type lettuce,
it only shows the 9.1-kb DNA fragment. Also, all independent
transplastomic CTB-FVIII-SC lettuce lines showed two distinct
fragments at 10.3 kb and 5.4 kb due to an internal HindIII site
within the HC coding sequence (Figure 2b), while there was no
untransformed wild-type DNA fragment at 9.1 kb. Absence of
9.1-kb hybridizing fragment in transplastomic lines confirmed
that the homoplasmic lines for CTB-FVIII-LC and CTB-FVIII-SC
were successfully achieved after the 2nd round of antibiotic
selection (within limits of this detection system).

FVIII expression in transplastomic lettuce
For scale-up of the homoplasmic transplastomic lines expressing
CTB-FVIII-C2, CTB-FVIII-HC, CTB-FVIII-LC and CTB-FVIII-SC, the
confirmed lines were transferred to soil in the glasshouse at the
University of Pennsylvania and the cGMP facility in Fraunhofer,
USA. The leaves harvested from fully grown lettuce were
lyophilized as described in the previous study (Kwon et al.,
2016). The expressed amounts of CTB-FVIII-C2, CTB-FVIII-HC,
CTB-FVIII-LC and CTB-FVIII-SC fusion proteins in lyophilized
lettuce grown in glasshouse were 367, 324, 263 and 26 lg/g
dry weight (DW) of total protein, respectively (Figure 2c). In
cGMP hydroponic system, the expressed amounts of CTB-FVIIIC2, CTB-FVIII-HC and CTB-FVIII-SC in the first harvest (day 26)
were 3321, 3622 and 243 lg/g DW in lyophilized plant cells. So,
there is an increase of 9- to 11-fold higher expression when plants
are grown in hydroponic system than on soil in the glasshouse.
From Western blot results (Figure 2d), expression level of 26-day
(after seed germination) leaves was 243 lg/g DW; however, the
expression level of 48-day and 96-day leaves was increased to
615 and 852 lg/g DW, respectively.
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Figure 1 Chloroplast expression vectors, evaluation of expression in E. coli and CTB-FVIII integration into chloroplast genomes. (a) Chloroplast expression
cassette containing CTB-fused codon-optimized FVIII single chain (SCC), heavy chain (HCC) and light chain (LCC). Prrn, rRNA operon promoter; aadA,
aminoglycoside 30 - adenylyltransferase gene; PpsbA, promoter; and 50 -UTR of psbA gene; CTB, native coding sequence of cholera nontoxic B subunit; FVIIISCC, a fusion form of codon-optimized FVIII heavy chain (HCC including 14 amino acids from B domain) and light chain (LCC); TpsbA, 30 -UTR of the psbA
gene; trnI, isoleucyl-tRNA; trnA, alanyl-tRNA; 16s and 23s rRNA, 16s and 23s ribosomal RNA, respectively. Southern blot – probe (SB-P, 1.1 kb) generated
from the flanking sequence; genomic DNA was digested by HindIII. (b) Western blot assays for CTB-FVIII protein expression of native (N) or codon-optimized
(C) for HC, LC and SC in E. coli. Protein size: CTB-FVIII-SC, 178.2 kDa; CTB-FVIII-HC, 99.3 kDa; CTB-FVIII-LC, 91.8 kDa. (c) and (d) are PCR analysis of the
integration of CTB-FVIII-LCC and of CTB-FVIII-SCC of transgenic lettuce. The primers used for PCR analysis are shown in A. UT, untransformed wild-type
DNA; L1–L8, eight independent CTB-FVIII-LCC transplastomic lines; S1–S3, three independent CTB-FVIII-SCC transplastomic lines; M, DNA 1kb plus marker.

For evaluation of stability after long-term storage, transplastomic lettuce grown in hydroponic system was harvested on days
as indicated in Figure 2d and immediately stored in -80C deep
freezers. Then, different batches were lyophilized on the same
day and stored for another 6 months at room temperature. The
western blot results give us information on not only the
expression levels of each batch but also their stability in
lyophilized plant cells when stored at ambient temperature.
CTB-fused FVIII proteins are still intact without any noticeable
degradation after 6 months of storage (Figure 2d). Formation of
pentameric structures of full-length CTB-FVIII was evaluated using
GM1-ganglioside receptor binding ELISA assay. CTB-FVIII-SC
showed comparable absorbance to CTB and CTB-FIX (Figure 2e),
indicating that it has GM1 binding ability as strong as purified
CTB protein and CTB-FIX clotting factor, despite the large size
(891 kDa) of assembled pentamer. This result confirms correct
folding, assembly, disulphide bonds and stability of the CTB-FVIIISC pentameric structure in lyophilized leaves.

Lettuce-made CTB-FVIII antigen suppresses inhibitor
formation in haemophilia A mice
Formation of inhibitory antibodies is a major complication in
the clotting factor replacement therapy for haemophilia, as
these ‘inhibitors’ prevent the therapeutic coagulation factor
from promoting blood clot formation (Batsuli et al., 2016). In
our previously published study on oral tolerance induction to

FVIII (Sherman et al., 2014), we demonstrated that codelivery
of frozen tobacco cells expressing CTB fusions of HC and C2
domain at a dose of 5 lg per antigen could substantially
suppress inhibitor formation. To test for effectiveness of
lyophilized cells, which can be stored at ambient temperature
for long periods of time, we tested the identical regimen of
two oral gavages per week for 2 months in haemophilia A
mice, which were challenged with 4 weekly intravenous
injections of B domain-deleted (BDD) human FVIII (1 IU/dose)
during the second month of the experiment (Figure 3a).
However, substantially lower doses of 0.5–1.7 lg per antigen
contained in lyophilized tobacco cells were orally delivered. As
shown in Figure 3b, up to eightfold suppression of inhibitor
titres (as determined by Bethesda assay; P < 0.01, n = 9/group)
was achieved when compared to control mice that were
challenged with intravenous FVIII without having received oral
antigen. Suppression of binding antibodies was twofold (as
measured by ELISA; P < 0.01, Figure 3c). Next, we directly
compared lyophilized tobacco and lettuce for oral tolerance
induction using again the combination of CTB-FVIII-C2 and
CTB-FVIII-HC (with lettuce expressing codon-optimized HC). At
doses of 0.5 lg per antigen, both tobacco and lettuce cells
were equally effective in suppression of inhibitors and binding
antibodies (on average ~3-fold in this experiment, P < 0.01,
n = 7–11/group; Figure 4a–c). Interestingly, an even lower dose
of 0.15 lg per antigen of lyophilized lettuce was at least as
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Figure 2 Characterization of CTB-FVIII transplastomic lettuce lines. (a) and (b) Southern blot analysis: (a) CTB-FVIII-LCC. UT, untransformed wild-type DNA;
L1–L8, eight independent CTB-FVIII-LCC lines. (b) CTB-FVIII-SCC; S1–S3, three independent CTB-FVIII-SCC lines. Total lettuce genomic DNA (3 lg) was
digested with HindIII. (c) and (d) Western blot analysis of lyophilized lettuce: (c) CTB-FVIII-SCC (178.2 kDa), CTB-FVIII-HCC (99.3 kDa) and CTB-FVIII-LCC
(91.8 kDa) expression in soil (glasshouse) or hydroponic (cGMP) systems. (d) Expression level of CTB-FVIII-SCC at different stages of growth in the
hydroponic system and evaluation of stability of CTB-FVIII-SCC protein in lyophilized plant cells after 6-month storage at ambient temperature. Protein
loaded in each lane and expression level based on CTB standards are shown below each lane. UT: untransformed control. (e) GM1 binding assay: CTB-FVIIISCC, CTB-FIX (Herzog et al., 2017; Su et al., 2015b) and untransformed (200 lg total protein); CTB (4, 8 and 20 ng); 1% BSA. Data shown are
means  SD of triplicates.

effective, suppressing antibody formation by three- to fivefold
(Figure 4b,c). Finally, we used the same experimental protocol
to test codelivery of lyophilized lettuce expressing CTB fusions
of FVIII-HC and FVIII-LC (both codon-optimized), therefore
delivering the entire B domain-deleted FVIII antigen. Here, a
dose of 0.5 lg per antigen (n = 6) suppressed inhibitor
formation on average sixfold and formation of binding
antibodies by twofold compared with the control group
(n = 14), nearly reaching statistical significance (P = 0.05;
Figure 4d,e). However, a dose of 1.5 lg per antigen (n = 6)
significantly and more robustly suppressed inhibitor formation
on average 9.3-fold (with 50% showing 0–3 BU/mL) and
formation of binding antibodies by fourfold (P < 0.05; Figure 4d,e). Regardless of FVIII antigen dose, all mice that
received oral delivery of CTB-FVIII-HC/CTB-FVIII-LC had inhibitor
titres <25 BU/mL to undetectable (with 50% showing 0–3
BU/mL), while nine of 14 control mice (64%) had titres of
>25 BU/mL, and three of 14 (21%) had very high titres of
>100 BU/mL, and 100% were >3 BU/mL (Figure 4d).
While the studies summarized above addressed prevention of
inhibitor formation, our previous studies suggested that plantbased oral tolerance may also be useful in reversal of FVIII
inhibitors. To further address this point, we performed the 2month oral tolerance regimen, using lyophilized lettuce (CTBFVIII-HC and CTB-FVIII-C2 mixture, 0.5 lg/antigen/dose), in
haemophilia A mice with pre-existing inhibitors (average titre of
28 BU, n = 13). At the end of the experiment, a 3- to 3.5-fold

reduction in anti-FVIII titres was observed (Figure 5a–c). Inhibitor
titres were on average reduced by 71% compared with starting
titres (P < 0.05). In contrast, control mice that had an average
starting titre of 20 BU (n = 9) but did not receive oral treatment
showed only a marginal spontaneous decline by <1.5-fold (31%–
32% reduction compared with starting titres, Figure 5d-e).
Therefore, consistent with our previous results using tobacco,
oral immune modulatory therapy accelerated the decline in
inhibitor titres.

LAP as a potential biomarker for oral tolerance
induction
Previously, we found that plant-based oral tolerance induces
multiple subsets of regulatory T cells (Treg) that suppress antibody
formation specifically to the fed antigen. These include
CD4+CD25+FoxP3+ Treg, as well as CD4+CD25FoxP3 Treg
that express latency-associated peptide (LAP) (Sherman et al.,
2014; Wang et al., 2015). Antigen-specific CD4+CD25+FoxP3+
Treg typically are present at low frequency, so that it may be
difficult to detect their induction by measuring overall frequencies. However, their activation may be detected by up-regulation
of LAP expression. Therefore, we determined the frequency of
both LAP+CD25FoxP3 cells among circulating CD4+ T cells and
LAP+ cells among circulating CD4+CD25+FoxP3+ cells in haemophilia A mice that received either preventive or interventional oral
tolerance (Figure 6a). These were compared to na€ıve mice or
mice that received only intravenous FVIII injections. Depending on
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Figure 3 Suppression of inhibitor formation in haemophilia A mice using low doses of FVIII antigens bioencapsulated in lyophilized tobacco. (a)
Experimental timeline of oral gavages and intravenous treatment with FVIII. (b) Inhibitor titres in mice that received gavages of 0.5 lg CTB-HC mixed with
0.5 lg CTB-C2 in a total volume of 100 lL PBS or 1.7 lg of each antigen in either 100 or 200 lL PBS, compared with control mice (intravenous FVIII
challenge only, no oral treatment). (c) FVIII-specific IgG formation in the same experimental groups. Shown are data point for individual mice, average
values and standard deviations. Fold difference and statistical significance are indicated for comparison between each experimental group and the control
group (n = 8–9/group). Significance is indicated as * for P<0.05 and ** for P<0.01.

the
comparison,
increase
in
frequency
of
LAP+CD4+CD25FoxP3 Treg did not always reach statistical
significance (Figure 6b,d). In contrast, increase in LAP+ cells
among CD4+CD25+FoxP3+ was consistently statistically significant (Figure 6c,e).

Discussion
Codon optimization
To achieve adequate levels of expression of CTB-FVIII gene
suitable for clinical translation, we first codon-optimized FVIII-HC
and FVIII-LC separately and verified translation enhancement in
E. coli because of similarity between E. coli and chloroplast
transcription/translation systems (Brixey et al., 1997). Observed
results show that the CTB-FVIII-LC expression was increased 15to 42-fold after codon optimization when compared to the native
human gene. In the previous study (Kwon et al., 2016), the
expression level of CTB-FVIII-HC from the codon-optimized gene
was increased eightfold higher than that of lettuce expressing the
native CTB-FVIII-HC gene. For the carrier protein, the expression
level of native CTB fused with proinsulin was 72% of total leaf
protein in tobacco chloroplasts (Ruhlman et al., 2010) and 53%
of total leaf protein in lettuce chloroplasts, which demonstrated
that there was no limitation on translational initiation and
elongation of N-terminal CTB sequence in chloroplasts. Hence,
the native CTB bacterial sequence was used in this study without
codon optimization. Likewise, the native human FVIII-C2
sequence was used for the expression in lettuce chloroplast
because of its high capacity of expression in chloroplast as shown
in our previous study (Sherman et al., 2014)

FVIII expression in the homoplasmic lettuce
After confirmation of improved expression of these two separate
synthetic genes (HC and LC) in chloroplasts, the two codonoptimized genes were fused into a single chain (SC) and
transplastomic lettuce lines were created. Expression levels of
FVIII proteins were not high when grown in the glasshouse in soil
because of less-than-optimal growth conditions. In addition,

clinical translation would require production of biomass in a
cGMP facility. Therefore, transplastomic lines were grown in
Fraunhofer USA hydroponic facility. The level of CTB-FVIII-SC
expression of the transplastomic lettuce from hydroponically
germinated and grown was ninefold, 24-fold and 33-fold higher
in the first, second and third harvest than that of soil-grown
lettuce plants. In the first harvest, different FVIII proteins showed
nine- to 11-fold higher expression when grown hydroponically
than in soil in the glasshouse.
As well documented in the previous studies, increased nitrogen
supply enhances plant growth and photosynthetic capacity
through the increase of stromal and thylakoid proteins and
chloroplast protein synthesis (Evans, 1989; Joel et al., 1997;
Makino et al., 1992). The conversion efficiency of photosynthetically active radiation to biomass was reduced by 30%–35% in
nitrogen- and water-limited conditions (Joel et al., 1997). Also, as
nitrogen supply increases, the ratio of Rubisco to chlorophyll and
to electron transport activity was increased (Makino et al., 1992).
Because Calvin cycle enzymes and thylakoid proteins account for
the majority of the leaf nitrogen, the photosynthetic capacity of
leaves has a close correlation with the nitrogen content (Evans,
1989). So continuous supply of nitrogen with no water stress in
the hydroponic system should have increased the photosynthetic
capacity of the lettuce leaves and enhanced chloroplast protein
synthesis. Indeed, a previous report has shown that the additional
supply of nitrogen is essential to maintain Rubisco levels in
chloroplasts when very high levels of foreign proteins are
expressed in chloroplasts (Bally et al., 2009).
For CTB fusion proteins, the pentameric structure is essential
for binding to GM1-ganglioside receptor on the epithelial cells of
intestinal. Even though CTB-fused FVIII-SC is the largest protein
expressed so far in chloroplasts (pentamer size 891 kDa), the
GM1 binding assay confirmed that despite this large size, GM1
binding efficiency is as efficient as CTB or other well-characterized
CTB-FIX that were successfully tested in haemophilia B dogs
(Herzog et al., 2017) and mice (Su et al., 2015b). Insertion of 10
amino acids in between CTB and FVIII-SC should help mitigate
steric hindrance, otherwise interfering with the proper assembly

ª 2017 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd., 16, 1148–1160

1154 Kwang-chul Kwon et al.

Figure 4 Suppression of inhibitor formation in haemophilia A mice using low doses of CTB-FVIII-HC/-C2 antigens or CTB-FVIII-HC/-LC (containing the
entire B domain-deleted FVIII sequence) bioencapsulated in lyophilized lettuce. (a) Experimental timeline of oral gavages and intravenous treatment with
FVIII. (b) Inhibitor titres in mice that received gavages of 0.15 lg CTB-FVIII-HC mixed with 0.15 lg CTB-FVIII-C2 in a total volume of 100 lL PBS or 0.5 lg of
each antigen in 100 lL PBS, compared with control mice (intravenous FVIII challenge only, no oral treatment) and mice that received 0.5 lg of each antigen
bioencapsulated in lyophilized tobacco. (c) FVIII-specific IgG formation in the same HC/C2 experimental groups. Fold difference and statistical significance
are indicated for comparison between each experimental group and the control group (n = 7–11/group). (d) Inhibitor titres in mice that received gavages of
the entire B domain-deleted FVIII amino acid sequence by mixing 0.5 lg CTB-FVIII-HC (heavy chain) with 0.5 lg CTB-FVIII-LC (light chain) in a total volume
of 100 lL PBS or 1.5 lg of each antigen in 100 lL PBS, compared with control mice (intravenous FVIII challenge only, no oral treatment). (e) FVIII-specific
IgG formation in the same CTB-FVIII-HC/-LC experimental groups. Shown are data point for individual mice, average values and standard deviations. Fold
difference and statistical significance are indicated for comparison between each experimental group (n = 6/group) and the control group (n = 14).
Significance is indicated as * for P<0.05 and ** for P<0.01.

of pentamer, while forming CTB pentameric structure. Furthermore, this protein is still intact without any detectable cleaved
product after 9-month storage and efficient GM1 binding
confirms pentamer assembly with disulphide bonds after
9 months of storage of lyophilized cells at ambient temperature.
According to our previous studies (Herzog et al., 2017; Su et al.,
2015b), the CTB-fused FIX expressed by chloroplast can be stored
in lyophilized leaves up to 30 months. Our result confirmed again
that the recombinant protein stored in lyophilized plant cell can
be preserved for a long time at room temperature without losing
their efficacy.

Suppression of inhibitor formation against FVIII is
effective at low antigen doses bioencapsulated in
lettuce
In our published studies, we achieved ~7-fold reduction in
average inhibitor titres in haemophilia A mice in response to
intravenous FVIII replacement therapy when animals were
pretreated orally twice per week with 5 lg CTB-FVIII-HC

combined with 5 lg CTB-FVIII-C2 antigens bioencapsulated in
frozen transplastomic tobacco leaf cells. Here, we find up to
eightfold suppression using a 10-fold lower antigen dose in oral
delivery of lyophilized cells, which have the advantage of being
stable during long-term storage at ambient temperature (Herzog
et al., 2017; Su et al., 2015b). Therefore, lyophilized cells are
equally effective as frozen cells, and consistent with our previous
findings with FIX, oral tolerance can be achieved at very low
antigen doses. The slightly higher effectiveness of the lowest
antigen dose (0.5 lg) over a threefold higher dose in the case of
lyophilized tobacco may reflect that in contrast to lettuce, the HC
was not codon-optimized and therefore not as highly expressed,
so that a greater amount of plant cells had to be fed, which may
not have been entirely digested in the mouse intestine. Previous
studies with highly expressed CTB-FIX in haemophilia B mice
showed equal efficacy over a dose range of at least 10-fold (Su
et al., 2015b; Verma et al., 2010).
Equally important for translational studies in humans, bioencapsulation in the edible crop plant lettuce showed equal efficacy for
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Figure 5 Reversal of inhibitor formation in
haemophilia A mice using FVIII antigens
bioencapsulated in lyophilized lettuce. (a)
Experimental timeline of immunization and oral
delivery. (b) Inhibitor titres as a function of time in
mice that received gavages of 0.5 lg CTB-FVIIIHC mixed with 0.5 lg CTB-FVIII-C2. (c) FVIIIspecific IgG formation in the same experimental
group (n = 13). Fold difference is indicated for
comparison between initial and final antibody
titres. (d) Inhibitor titres as a function of time in
control mice that did not receive oral antigen. (e)
FVIII-specific IgG formation in the same
experimental group (n = 13). Shown are data
point and average values  standard deviation.
Significance is indicated as * for P<0.05 and ** for
P<0.01 (while “ns” is not significant).

oral tolerance as tobacco. In fact, an even further reduction in the
antigen dose to 0.15 lg, ~30-fold lower than the original dose in
our published tobacco study (Sherman et al., 2014), was equally
effective. Using LC instead of C2, an adjusted dose of 1.5 lg was
superior to a lower dose. The LC is comprised of A3, C1 and C2
domains. The C2 domain is one of the most immunogenic parts of
FVIII and contains CD4+ T-cell epitopes in the human population as
well as in mice. Furthermore, the C2 domain is considered critical
for tolerance induction in haemophilia A mice (Lei and Scott,
2005). As the LC is fourfold larger than the C2 domain, an equal
antigen amount represents approximately four times as many CTBFVIII-C2 molecules compared with CTB-FVIII-LC. CTB fusions
effectively target the GM1 receptor on epithelial cells of the small
intestine for effective antigen uptake and transmucosal delivery to
the gut immune system. It is possible that the smaller CTB-C2
antigen may be somewhat more effectively delivered through this
mechanism. Nonetheless, we achieved a similar level of suppression of inhibitor formation (eightfold) using a ~3-fold lower antigen
dose as previously published (Sherman et al., 2014) with the HC/
LC antigen combination. While it is likely not necessary to cover all
CD4+ T-cell epitopes with the orally delivered antigen in an
individual person (because induced Treg should suppress responses
to other parts of the molecule, Kim et al., 2015), the human
population is diverse with regard to MHC II genes and T-cell
epitope usage. Therefore, in some patients, inclusion of the C1
domain may be more critical than the C2 domain. Hence, coverage
of the entire molecule for oral antigen delivery should be most
beneficial for treatment of the human patient population. In
summary, we accomplished multiple critical steps towards oral

tolerance induction to FVIII in haemophilia A patients. Specifically,
we showed effectiveness of low antigen doses in leaf cells
(prepared in a form that is ideal for stable long-term storage) of
a crop plant that is suitable for human application, and we covered
the entire antigen. Low antigen doses both reduce manufacturing
costs and facilitate administration and dose-finding studies in
humans.
Reversal of an established immune response is typically more
difficult than prevention. However, our results support a utility in
oral tolerance in inhibitor reversal as well. Currently, inhibitor
patients are subjected to ITI (immune tolerance induction)
protocols, which typically involve high-dose daily intravenous
infusion of FVIII, which can take months and is very expensive. In
addition, these protocols are more effective when initiated after
inhibitor titres spontaneously declined to lower levels. This period
of time adds to the duration of increased risks of morbidity and
mortality. Certain types of immune suppression may be an
alternative (Biswas et al., 2017). However, our new data with
lettuce and published results with tobacco reproducibly show that
plant-based oral tolerance can accelerate the decline of preexisting inhibitors and could therefore be incorporated into future
ITI protocols (Sherman et al., 2014). Reversal of FIX inhibitors and
of anaphylaxis in haemophilia B mice further support a role for
oral tolerance in reversal of immune responses in the treatment of
haemophilia (Wang et al., 2015).

Towards cellular biomarkers of oral tolerance induction
Translational oral tolerance studies in humans are complicated by
the variability of the response to FVIII. It would therefore be
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Figure 6 LAP as a potential biomarker expressed
by Treg that are induced by oral tolerance. (a)
Gating scheme and fluorochrome usage in flow
cytometric analysis of peripheral blood cells from
haemophilia A mice. (b) Frequencies of
LAP+CD25FoxP3 Treg among total circulating
CD4+ T cells after 2 months of oral delivery of
CTB-FVIII-HC/CTB-FVIII-C2 antigen mixture
bioencapsulated in lettuce (with weekly
intravenous FVIII challenge during the second
month, n = 14). Comparison between control
mice that received intravenous FVIII only (n = 5)
and na€ıve mice (n = 5). (c) Frequencies of LAP+
cells among circulating CD4+CD25+FoxP3+ Treg in
the same experimental groups. (d) Frequencies of
LAP+CD25FoxP3 Treg among total circulating
CD4+ T cells after 1 month of oral delivery of CTBFVIII-HC/CTB-FVIII-C2 antigen mixture
bioencapsulated in lettuce in animals with preexisting inhibitors (n = 14). Comparison between
control mice that received intravenous FVIII only
(n = 9) and na€ıve mice (n = 5). (e) Frequencies of
LAP+ cells among circulating CD4+CD25+FoxP3+
Treg in the same experimental groups. Shown are
data point for individual mice, average values,
standard deviations and statistically significant
differences.

helpful to include a panel of biomarkers to clinical trial design. In
previous studies, we found that oral antigen delivery followed by
challenge with intravenous antigen induced two subsets of Treg
that suppressed antibody formation against FVIII or FIX
systemically. These were CD4+CD25+FoxP3+ Treg and
LAP+CD4+CD25FoxP3 Treg. The latter were most robustly
induced in the gut immune system (e.g. in Peyer’s patches and
mesenteric lymph nodes), but were also detectable in the spleen
(Sherman et al., 2014; Wang et al., 2015). LAP+ Treg overexpress
the immune-suppressive cytokine TGF-b, and their ability to
suppress immune responses is also TGF-b-dependent (Ochi et al.,
2006). Here, we also find increases in the frequencies of these
cells in peripheral blood, albeit a significant increase was not
always observed when compared to the blood of control mice
that received intravenous FVIII but not oral tolerance. Antigenspecific CD4+CD25+FoxP3+ Treg tend to suppress at low
frequencies, so that we did not observe significant increases in
their overall frequency, but were able to demonstrate their
induction by adoptive transfer (Sherman et al., 2014; Wang
et al., 2015). However, their activation may result in induction of
LAP expression on the cell surface (Tran et al., 2009a,b). Our new
data show significant increases in the frequencies of
LAP+CD4+CD25+FoxP3+ Treg in peripheral blood of tolerized

mice, suggesting that LAP, and in particular this subset of Treg,
may be a suitable cellular biomarker for plant-based oral
tolerance induction. Importantly, the human immune system also
contains LAP+ Treg (Gandhi et al., 2010).

Chloroplast expression system
Our study achieved expression of the highly challenging large
human FVIII single-chain protein (pentamer size 891 kDa) – the
largest foreign protein ever expressed in chloroplasts. The amino
acid sequence of FVIII-SC studied here is the same as that of
ReFacto or ReFacto AF, which are currently used in clinics as
replacement therapeutic FVIII products (Lind et al., 1995; Orlova
et al., 2013). Although efficacy of CTB-FVIII single chain has not
yet been fully investigated in animal studies, a single candidate
protein target should offer several advantages. First, it meets the
clinical need because it covers the entire patient population,
regardless of individual CD4+ T-cell epitope responses. Secondly,
regulatory approval cost is significantly reduced for a single
protein versus two different protein targets. Because the light
chain and heavy chain are equal in dosage and efficacy, there is
no need to change their ratios while administering this drug.
Most importantly, the negative impact of the light chain (slow
growth, sterility) is mitigated by fusion with the heavy chain. As
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seen in our previous report (Su et al., 2015a), the phenotypes
observed from LC lettuce could be a result of a deleterious effect
from the binding of the LC with an essential chloroplast protein.
Transplastomic plants expressing CTB-fused truncated form of
acid alpha glucosidase (410 aa of N-terminal GAA) showed yellow
or albino phenotype and full-length GAA could never be
expressed in chloroplasts (Su et al., 2015a). This was due to a
possible disruption of normal metabolism in chloroplast as a
consequence of the binding of the truncated GAA to mannose 6phosphate receptor or the homologue in the chloroplast (Su
et al., 2015a). Another possible explanation could be inferred
from a recent study, which showed that the LC itself is sufficient
for accelerating cleavage of von Willebrand factor (VWF) by
metalloprotease (A disintegrin and metalloprotease with thrombospondin type 1 repeats, ADAMTS13) (Cao et al., 2012). So, the
LC could probably impact chloroplast proteases, growth of
transplastomic lines and fertility. However, it appears that the
fusion of HC with LC minimized detrimental impact of the LC.
This is the first report of animal studies expressing FVIII-HC,
FVIII-C2 and FVIII-LC made in lettuce chloroplasts. Combination
of FVIII-HC/FVIII-LC, spanning the entire FVIII antigen, has never
before been evaluated in tobacco or lettuce. Furthermore, we
compared efficacy of transplastomic tobacco and lettuce
because there is still hesitation among investigators in this field
regarding reproducibility of an edible system when compared to
a model system on critical requirements including level of
transgene expression, differences in bioencapsulation to protect
protein drugs in the stomach, etc. Likewise, previous studies
used frozen tobacco cells for oral gavage, whereas this study
used lyophilized lettuce cells, which facilitates long-term storage
at ambient temperature and is critical for clinical feasibility. We
are delighted to report here our observation that the lyophilized
lettuce system is as efficient as the frozen tobacco system at
very low dose of plant material (≤2.25 mg versus 125 mg per
gavage). Therefore, lyophilized lettuce FVIII can be advanced to
the clinic.
This study achieved a high level of expression of a large
human FVIII single-chain protein, the largest foreign protein
ever expressed in chloroplasts. This study demonstrates that
chloroplast expression system can indeed be further optimized
to meet clinical needs by enhancing translation through codon
optimization, utilizing recent advances in genomics and genetic
engineering. Although biomass is produced in controlled
facilities, unintentional dispersal of human genes is always a
critical concern of genetically modified plants. Therefore,
maternal inheritance of chloroplast genome offers transgene
containment via pollen or seeds because biomass is harvested
before appearance of reproductive structures (Daniell, 2007;
Daniell et al., 2016a; Jin and Daniell, 2015). Most importantly,
therapeutic proteins expressed in chloroplasts can be stably
stored at ambient temperature for several years without
decrease in their functionality (Herzog et al., 2017; Su et al.,
2015b). In this study, we showed that an antigen combination
that covers the entire amino acid sequence of BDD-FVIII (HC
and LC), one of the commonly used therapeutic versions of
FVIII, is effective. Oral delivery of therapeutic proteins bioencapsulated in plant cells significantly reduces cost of biopharmaceuticals by elimination of expensive fermentation,
purification, cold storage and sterile injections. Therefore,
CTB-FVIII expressed in lettuce chloroplasts will benefit patients
with increased compliance, lower cost and induction of immune
tolerance after receiving FVIII injections.

Materials and methods
Codon optimization of human FVIII genes and
construction of chloroplast vectors
The native sequences of FVIII genes were codon-optimized,
except for C2, based on the codon table which was developed by
analysis of psbA genes from 133 plant species (Kwon et al.,
2016). The eukaryotic genes were optimized by adapting the
codon usage hierarchy of the most highly expressed chloroplast
psbA gene. The codon-optimized FVIII-HC and FVIII-LC sequences
were synthesized by GenScript, and the codon-optimized FVIII-SC
was generated by overlapping PCR using the codon-optimized
FVIII-HC and FVIII-LC as templates. For FVIII-C2, the native C2
gene fragment was obtained from the previous construct, CTBFVIII-C2:pLD (Sherman et al., 2014), by digestion with restriction
enzymes. The synthetic and the native C2 gene sequences were
cloned into lettuce chloroplast transformation vectors pLsLF using
NdeI and XbaI restriction enzyme sites. Sequence-confirmed
plasmids were transformed into TOP10 E. coli cell and extracted
using PureYieldTM Plasmid Midiprep System (Promega, Madison,
WI).
For evaluation of the protein expression level in E. coli system,
overnight cultured E. coli cells in ampicillin-containing LB medium
were pelleted, resuspended in extraction buffer (1 9 PBS and
5 mM EDTA) and then sonicated to break down cells. The
homogenate of E. coli total protein was quantified using Bradford
assay, and equal amount of proteins was loaded after heating
samples at 70 °C for 15 min in 1 9 Laemmli buffer.

Generation of transplastomic lettuce
Three lettuce expression vectors pLsLF-CTB-FVIII-SCC, pLsLF-CTBFVIII-HCC and pLsLF-CTB-FVIII-LCC (Figure 1a) were transformed
into 4-week-old lettuce (Lactuca sativa) leaves by particle bombardment using 0.6-lm gold particle (Bio-Rad, Hercules, CA) in
900 psi (Verma et al., 2008). The bombarded leaves were subject
to multiple selection rounds in selection/regeneration medium
with spectinomycin (50 lg/mL). The regenerated shoots were
examined by PCR amplification and Southern blot assay using
specific primer sets and probes (Figure 1a). The sequences of
primers used for the PCR analysis are as below: 16sF, 5΄- CAGCA
GCCGCGGTAATACAGAGGATGCAAGC-3΄; 5P, 5΄-CTGTAGAAG
TCACCATTGT TGTGCACGACGAC-3΄; 3M, 5΄- CCGCGTTGTTTC
ATCAAGCCTTACGGTCACC-3΄; P-F, 5΄- ACAGCTGTCGACTAGT
GTATAGAAA TCCTT-3΄; H-R, 5΄-AGACATAATGGATCGGA GG
CCATAGGTCC G-3΄; L-F, 5΄-ACTACATTGCTGCAGAAGAAGAG
GATTGGGATTATG C-3΄; T-R, 5΄-GCAAGAGCGGA GCTCTAC
CAACTGAGCT A-3΄. Southern blot analysis for checking homoplasmic status of transplastomic lines was examined by following
the manufacturer’s instruction of DIG high prime DNA labelling
and detection starter kit II (Roche, Penzberg, Germany).
To generate a large scale of lettuce biomass, the transplastomic
lettuces were grown in two different cultivation systems, the
glasshouse (soil system) and cGMP facility (hydroponic system).
Seedling stage plants grown in in vitro culture system were
transferred onto soil in the glasshouse. The soil was mixed with a
1 : 1 ratio of garden soil (Miracle-Gro) and potting soil (Erthgro),
and the plants were fertilized with Miracle-Gro Water Soluble All
Purpose Plant Food once or twice per week under the conditions
of 16-h : 8-h light cycle at 22 °C. Cultivation of the lettuce in
hydroponic system was described in our previous study (Su et al.,
2015b). The hydroponic system included multilevel growth racks
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which were illuminated by three sealed lighting fixtures containing 2-T8 fluorescent bulbs. Each rack accommodated two growth
trays containing rockwool fibre as supporting substrates (Grodan,
the Netherlands) which are designed to hold water longer and
encourage faster initial rooting by providing 20% airspace while
absorbing nutrients when saturated. The nutrient with a 20-1020 ratio of nitrogen, phosphorus and potassium was supplied
when irrigated. Seedlings were spaced at 2 inch 9 2 inch on the
rockwool surface. Plants were exposed to light of an average of
70–90 lmol/m2/s on an 18-h photoperiod under the conditions
of temperature (23–26 °C) and humidity (20%–60%) in the
growth room. In cGMP hydroponic system, the transplastomic
lettuces were harvested in day 26, day 48 and day 96. After
sample harvested, lyophilization and preparation of powder of
lettuce leaves were carried out as described previously (Kwon
et al., 2016).

Total protein extraction and quantification
To evaluate the level of expression of the synthetic FVIII genes in
transplastomic lettuce, the harvested fresh lettuce leaves from
glasshouse or hydroponic systems were lyophilized and powdered
and then suspended in plant extraction buffer (100 mM NaCl;
10 mM EDTA; 200 mM Tris-Cl, pH 8.0; 0.05% (v/v) Tween-20;
0.1% SDS; 14 mM b-ME; 400 mM sucrose; 2 mM PMSF; 1 9 proteinase inhibitor cocktail) in a ratio of 10 mg per 500 lL and
rehydrated with intermittent vortex in 4 °C. The rehydrated plant
cells were sonicated in pulse on for 5 s and pulse off for 10 s by
sonicator 3000 (Misonix, Farmingdale, NY). After protein quantification by Bradford assay, equal amounts of homogenized
proteins were heated at 70 °C in 1 9 Laemmli buffer for 15 min.
SDS-polyacrylamide page (8%, fixed) was used for Western
blots. To probe CTB fusion proteins, anti-CTB antibody
(1 : 10000) (GenWay Biotech, San Diego, CA) and goat antirabbit IgG-HRP secondary antibody (1 : 4000) (Southern Biotechnology, Birmingham, AL) were used. Chemiluminescent substrate
(Thermo Fisher, Waltham, MA) was added for detecting HRP on
the immunoblots, and the signals were exposed onto X-ray films,
and then, developed bands were used for quantitative analysis
with ImageJ software (IJ 1.46r; NIH).

GM1-ganglioside receptor binding assay
To evaluate the ability of the lettuce chloroplast-derived CTB-FVIII
to form pentamers and bind to the GM1-ganglioside receptor, a
CTB-GM1 binding assay was performed. For CTB-FVIII protein
extraction, lyophilized plant powder was suspended in extraction
buffer in a ratio of 10 mg per 500 lL and mixed by vortexing for 1 h
at 4 °C for rehydration. Suspended powder was sonicated (pulse
on for 5 s and pulse off for 10 s; sonicator 3000; Misonix) after
vortexing. CTB-GM1 binding assay was carried out by following the
protocol described previously (Ruhlman et al., 2007).

Haemophilia A mouse experiments
Male haemophilia A mice (F8e16/) on BALB/c background,
2 months of age at the onset of experiments and housed under
SPF conditions at University of Florida CGRC facility, received oral
gavage of mixture CTB-FVIII-C2 and CTB-FVIII-HC lyophilized
tobacco or lettuce leaf cells (suspended in 100–200 lL of sterile
phosphate-buffered solution) twice per week for 2 months. At
the beginning of the second month, mice received weekly
intravenous injection of 1 IU/mouse of recombinant BDD-FVIII
concentrate (Xyntha, Prizer, New York, NY), for a total of four
injections. One week after last IV injection, blood was collected

via retro-orbital route into citrated buffer, and blood cells were
removed by centrifugation. Plasma was and assessed for
inhibitors (by Bethesda assay) and for FVIII-specific IgG (by ELISA)
as published (Sherman et al., 2014).

Flow cytometry
Murine blood samples were pre-incubated with rat anti-mouse
CD16/32 (Pharmingen, Franklin Lakes, NJ) and then stained with
a mixture of eFluor 450 CD4 (eBioscience, Waltham, MA), BV605,
anti-mouse CD25 (Biolegend, San Diego, CA) and PE anti-mouse
LAP (Biolegend). Intracellular staining for forkhead box P3 (FoxP3)
was performed with FoxP3 staining kit (eBioscience). Data were
collected on LSR II flow cytometer (BD Bioscience, San Jose, CA)
and analysed with FCS express software (De Novo Software,
Glendale, CA).

Statistical analysis
Differences between two experimental groups were compared by
unpaired two-tailed Student’s t-test. Results are reported as
means  standard error of mean (SEM). Differences are indicated as *P < 0.05, **P < 0.01 and ns = not significant.
GraphPad Prism software (San Diego, CA) was used to perform
analysis.
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